Cargando...
Excellent response of intramedullary Erdheim-Chester disease to vemurafenib: a case report
BACKGROUND: Erdheim-Chester disease is a rare histiocytosis characterized by multi-systemic organ involvement. Immune-modulating agents such as interferon-alpha have limited success and the disorder is progressive and causes high morbidity and mortality. Treatment with the BRAF-inhibitor vemurafenib...
Gardado en:
| Publicado en: | BMC Res Notes |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BioMed Central
2015
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4450489/ https://ncbi.nlm.nih.gov/pubmed/25926131 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13104-015-1135-7 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|